These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 19798700

  • 1. Histological, immunocytochemical, and morphometrical analyses of pancreatic islets in the BSB mouse model of obesity.
    Slavin BG, Zarow C, Warden CH, Fisler JS.
    Anat Rec (Hoboken); 2010 Jan; 293(1):108-16. PubMed ID: 19798700
    [Abstract] [Full Text] [Related]

  • 2. Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice.
    Yamanaka M, Itakura Y, Inoue T, Tsuchida A, Nakagawa T, Noguchi H, Taiji M.
    Metabolism; 2006 Oct; 55(10):1286-92. PubMed ID: 16979397
    [Abstract] [Full Text] [Related]

  • 3. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
    Jetton TL, Liang Y, Cincotta AH.
    Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060
    [Abstract] [Full Text] [Related]

  • 4. A morphological and immunohistochemical investigation of endocrine pancreata from obese ob+/ob+ mice.
    Starich GH, Zafirova M, Jablenska R, Petkov P, Lardinois CK.
    Acta Histochem; 1991 Nov; 90(1):93-101. PubMed ID: 1675542
    [Abstract] [Full Text] [Related]

  • 5. Insulin and glucagon: plasma levels and pancreatic release in the genetically obese Zucker rat.
    Bryce GF, Johnson PR, Sullivan AC, Stern JS.
    Horm Metab Res; 1977 Sep; 9(5):366-70. PubMed ID: 336502
    [Abstract] [Full Text] [Related]

  • 6. Changes in the islets of langerhans in the obese Zucker rat.
    Larsson LI, Boder GB, Shaw WN.
    Lab Invest; 1977 Jun; 36(6):593-8. PubMed ID: 325294
    [Abstract] [Full Text] [Related]

  • 7. Beta-cell function and mass in type 2 diabetes.
    Larsen MO.
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [Abstract] [Full Text] [Related]

  • 8. Effect of adrenalectomy on the pancreas of db/db mice.
    Spear GS, Ohshima K, Bray GA, Caple MV.
    Horm Metab Res; 1986 Nov; 18(11):743-5. PubMed ID: 2878865
    [Abstract] [Full Text] [Related]

  • 9. Did the gradual loss of GLUT2 cause a shift to diabetic disorders in the New Zealand obese mouse (NZO/Hl)?
    Chankiewitz E, Peschke D, Herberg L, Bazwinsky I, Mühlbauer E, Brömme HJ, Peschke E.
    Exp Clin Endocrinol Diabetes; 2006 May; 114(5):262-9. PubMed ID: 16804801
    [Abstract] [Full Text] [Related]

  • 10. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
    Green BD, Lavery KS, Irwin N, O'harte FP, Harriott P, Greer B, Bailey CJ, Flatt PR.
    J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
    [Abstract] [Full Text] [Related]

  • 11. Estrogenic restoration of functional pancreatic islet cytoarchitecture in diabetes (db/db) mutant C57BL/KsJ mice: relationship to estradiol localization, systemic glycemia, and persistent hyperinsulinemia.
    Garris DR, Garris BL.
    Cell Tissue Res; 2005 Feb; 319(2):231-42. PubMed ID: 15654653
    [Abstract] [Full Text] [Related]

  • 12. Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide: a comparison with its antidiabetic effects in non-obese diabetic mice.
    Piercy V, Toseland CD, Turner NC.
    Metabolism; 2000 Dec; 49(12):1548-54. PubMed ID: 11145115
    [Abstract] [Full Text] [Related]

  • 13. Glucose and insulin regulate glycosylphosphatidylinositol-specific phospholipase D expression in islet beta cells.
    Bowen RF, Raikwar NS, Olson LK, Deeg MA.
    Metabolism; 2001 Dec; 50(12):1489-92. PubMed ID: 11735099
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of pituitary adenylate cyclase-activating polypeptide in islets inhibits hyperinsulinemia and islet hyperplasia in agouti yellow mice.
    Tomimoto S, Hashimoto H, Shintani N, Yamamoto K, Kawabata Y, Hamagami K, Yamagata K, Miyagawa J, Baba A.
    J Pharmacol Exp Ther; 2004 May; 309(2):796-803. PubMed ID: 14742740
    [Abstract] [Full Text] [Related]

  • 15. Glycogen metabolism and cyclic AMP levels in isolated islets of lean and genetically obese mice.
    Newman ME.
    Horm Metab Res; 1977 Sep; 9(5):358-61. PubMed ID: 200536
    [Abstract] [Full Text] [Related]

  • 16. Quantitative histopathological assessment of retardation of islets of langerhans degeneration in rosiglitazone-dosed obese ZDF rats using combined insulin and collagens (I and III) immunohistochemistry with automated image analysis and statistical modeling.
    Jones HB, Bigley AL, Pemberton J, Randall KJ.
    Toxicol Pathol; 2013 Sep; 41(3):425-44. PubMed ID: 23047688
    [Abstract] [Full Text] [Related]

  • 17. Alteration of islet cell populations in spontaneously diabetic mice.
    Baetens D, Stefan Y, Ravazzola M, Malaisse-Lagae F, Coleman DL, Orci L.
    Diabetes; 1978 Jan; 27(1):1-7. PubMed ID: 340309
    [Abstract] [Full Text] [Related]

  • 18. Analysis of gene expression in pancreatic islets from diet-induced obese mice.
    Imai Y, Patel HR, Doliba NM, Matschinsky FM, Tobias JW, Ahima RS.
    Physiol Genomics; 2008 Dec 12; 36(1):43-51. PubMed ID: 18854371
    [Abstract] [Full Text] [Related]

  • 19. The relationship between the hyperplastic pancreatic islet and insulin insensitivity in obesity.
    Mahler RJ.
    Acta Diabetol Lat; 1981 Dec 12; 18(1):1-17. PubMed ID: 6452013
    [Abstract] [Full Text] [Related]

  • 20. Pancreatic islets of obese hyperglycemic mice (ob/ob).
    Tomita T, Doull V, Pollock HG, Krizsan D.
    Pancreas; 1992 Dec 12; 7(3):367-75. PubMed ID: 1594559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.